On Apr 16, 2026, CNS reported earnings of 0.79 USD per share (EPS) for Q1 26, missing the estimate of 0.81 USD, resulting in a -3.43% surprise. Revenue reached 145.64 million, compared to an expected 145.00 million, with a 0.44% difference. The market reacted with a +3.14% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of 0.82 USD, with revenue projected to reach 147.51 million USD, implying an increase of 3.80% EPS, and increase of 1.29% in Revenue from the last quarter.